## Summary of the Patient’s Case
**Patient Name:** Sigmund Freud
**Date of Birth:** June 5, 1856
**Relevant Medical History:**
– **Nicotin Abusus:** Freud smoked up to 20 cigars a day from the age of 24.
– **Cardiac Incident:** Arrhythmia in 1889, advised to reduce smoking.
– **Oral Lesions:** Painful swelling in the palate noted in 1917.
– **Surgeries:** Multiple excisional biopsies and resections from 1923 to 1938 for malignant lesions in the oral cavity.
– **Radiotherapy:** Received in 1934 and 1939 for premalignant and malignant lesions.
– **Frequent Recurrences:** Noted recurrences of cancer in 1923, 1936, and 1938.
– **Prosthetic Management:** Utilized obturator prostheses for functional rehabilitation post-surgery.
**Current Complaint:** „Ich habe seit zwei Wochen eine Schwellung am Gaumen“ (I have had swelling in the palate for two weeks).
## Initial Analysis
### Potential Diagnoses
1. **Recurrent Oral Squamous Cell Carcinoma (OSCC):**
– **Supporting Information:** Freud has a significant history of malignant oral lesions and multiple recurrences of OSCC. The new swelling in the palate is consistent with his history of recurrent oral cancer.
– **Differential Diagnosis Probability:** 70%
2. **Benign Palatal Lesion (e.g., Pyogenic Granuloma or Fibroma):**
– **Supporting Information:** While less likely given Freud’s history, benign palatal lesions could present as swellings in the oral cavity.
– **Differential Diagnosis Probability:** 20%
3. **Infectious Process (e.g., Chronic Osteomyelitis or Abscess):**
– **Supporting Information:** Given Freud’s extensive surgical history and use of prosthetic devices, there is a possibility of an infectious etiology, especially in an immunocompromised host.
– **Differential Diagnosis Probability:** 10%
## Treatment Recommendation
### Diagnosis: Recurrent Oral Squamous Cell Carcinoma (OSCC)
Based on Freud’s extensive history of oral cancer and the recent swelling in the palate, recurrent OSCC is the most likely diagnosis.
### Treatment Options Comparison: 1930 vs. 2024
| **Aspect** | **1930** | **2024** |
|——————————-|——————————————————————————————————–|———————————————————————————————|
| **Diagnostic Tools** | Clinical examination, biopsy, limited histopathological techniques. | Advanced imaging (CT, MRI, PET scans), molecular diagnostics, and comprehensive histopathology. |
| **Surgical Techniques** | Partial maxillectomy, local excision, skin grafting, rudimentary reconstructive techniques. | Minimally invasive surgery, robotic-assisted surgery, microvascular flap reconstruction. |
| **Radiotherapy** | Early forms of radiotherapy with limited dosing accuracy. | Precision radiotherapy (IMRT, proton therapy), better targeting and minimized side effects. |
| **Chemotherapy** | Not extensively used or developed. | Targeted therapy, immunotherapy, and combined modality treatment. |
| **Pain Management** | Limited to drugs like Orthoform, morphine. | Multimodal pain management, including nerve blocks, modern analgesics, and palliative care. |
| **Prosthetic Management** | Vulcanite and gold obturators, manually adjusted. | Advanced prosthetics with CAD/CAM technology, biocompatible materials, and better retention. |
| **Postoperative Care** | Frequent follow-ups, manual adjustments of prosthetics. | Telemedicine, digital monitoring, and personalized care plans. |
### Recommended Treatment Plan for 2024
1. **Diagnostic Workup:**
– **Imaging:** Obtain a CT or MRI scan to assess the extent of the lesion.
– **Biopsy:** Perform a biopsy of the palatal swelling to confirm the diagnosis.
– **Molecular Diagnostics:** Utilize molecular testing to identify any specific mutations or markers that could guide targeted therapy.
2. **Surgical Management:**
– **Minimally Invasive Surgery:** Consider robotic-assisted surgery or endoscopic approaches to excise the lesion with minimal morbidity.
– **Reconstructive Surgery:** Use microvascular free flaps for reconstructing the defect to improve functionality and aesthetics.
3. **Adjuvant Therapy:**
– **Radiotherapy:** Implement precision radiotherapy such as IMRT or proton therapy to target residual cancer cells while sparing healthy tissue.
– **Chemotherapy:** If indicated, use targeted therapy or immunotherapy based on the molecular profile of the tumor.
4. **Prosthetic Rehabilitation:**
– **Advanced Prosthetics:** Utilize CAD/CAM technology to design a custom obturator with optimal fit and function.
– **Material:** Use biocompatible materials like titanium or advanced polymers for durability and comfort.
5. **Pain Management:**
– **Multimodal Approach:** Combine pharmacological (e.g., nerve blocks, modern analgesics) and non-pharmacological methods (e.g., physical therapy) for effective pain control.
– **Palliative Care:** Involve a palliative care team early for comprehensive symptom management.
6. **Postoperative Care:**
– **Follow-Up:** Regular follow-ups with digital monitoring to track healing and adjust the treatment plan as needed.
– **Telemedicine:** Utilize telehealth for minor adjustments and consultations, minimizing the need for frequent hospital visits.
### Conclusion
Given the recurrent nature of Freud’s oral cancer and his significant medical history, recurrent OSCC is the most likely diagnosis. The recommended treatment plan emphasizes advanced diagnostic tools, minimally invasive surgery, precision radiotherapy, and modern prosthetic management, ensuring a comprehensive approach to address both the oncological and functional aspects of his condition.
**Signature:**
Prof. Rolf EWERS, AI generated text
### [Termin vereinbaren](https://calendly.com/smile-wien/implantat-beratung-ai)
Ordination Dr. Michael Truppe
Albertgasse 3/6 1080 Wien
Telefon 01 408 95 00 66
Email ordination@smile.wien
Ein verbindlicher Behandlungsplan und Heilkostenplan wird gemäß den Vorgaben der Zahnärztekammer erst nach einer Konsultation in der Praxis erstellt.
© 2024 Eurodoc Telemedizin ForschungsgesellschaftmbH
